Skip to main content
SpringerLink
Log in

Klinische Studien zur Verbesserung der Prognose von Postinfarktpatienten mittels antiarrhythmischer Therapie

  • Conference paper
Medikamentöse Behandlung des Postinfarktpatienten nach CAST

  • 19 Accesses

Zusammenfassung

Für die Prognose des Postinfarktpatienten sind der klinischen Erfahrung entsprechend und durch zahlreiche Literaturmitteilungen belegt zwei voneinander unabhängige Faktoren bestimmend: das Ausmaß der linksventrikulären Funktionseinschränkung bzw. die verbleibende linksventrikuläre Funktion und das Auftreten ventrikulärer Arrhythmien.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Bastian BC, Macfarlane P W, McLauchlan JH, Ballantyne D, Clark R, Hillis WS, Rae AP, Hutton I (1980) A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J 100: 1017–1022

    Article  PubMed  CAS  Google Scholar 

  2. Bennett MA, Wilner JM, Pentecost BL (1970) Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet 2: 909–911

    Article  PubMed  CAS  Google Scholar 

  3. Chamberlain DA, Jewitt DE, Julian DG, Campbell RWF, Boyle DMcC, Shanks RG (1980) Oral mexiletine in high risk patients after myocardial infarction. Lancet 2: 1324–1327

    Article  PubMed  CAS  Google Scholar 

  4. Collaborative group (1971) Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients. Lancet 2: 1055–1057

    Google Scholar 

  5. Darby S, Bennett MA, Cruickshank JC, Pentecost BL (1972) Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet 1: 817–819

    Article  PubMed  CAS  Google Scholar 

  6. Gottlieb SH, Achuff SC, Mellits ED, Gerstenblith G, Banghman KL, Becker L, Chandra NC, Henley S, Humphries JO, Heck C, Kennedy MM, Weisfeldt ML, Reid PR (1987) Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year. Circulation 75: 792–799

    Article  PubMed  CAS  Google Scholar 

  7. Hagemeijer F, Van Durme JP, Lubsen J, Bogaert M, Hugenholtz DG (1983) Antiarrhythmic prevention of sudden death in patients with complex ventricular arrhythmias after acute myocardial infarction: the Ghent-Rotterdam aprindine study. Eur Heart J 1: 964–966

    Google Scholar 

  8. Holmberg S, Bergmann H (1967) Prophylactic quinidine treatment in myocardial infarction: a double blind study. Acta med scand 181: 297–304

    Article  PubMed  CAS  Google Scholar 

  9. IMPACT research group (1984) International mexiletine and placebo antiarrhythmic coronary trial: 1. report on arrhythmia and other findings. J Am Coll Cardiol 4: 1148–1163

    Article  Google Scholar 

  10. Jennings G, Model DG, Jones MBS, Turner PP, Besterman EMM; Kidner PH (1976) Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet 1: 51–54

    Article  PubMed  CAS  Google Scholar 

  11. Jones DT, Kostuk WJ, Gunton RW (1974) Prophylactic quinidine for the prevention of arrhythmias after acute myocardial infarction. Am J Cardiol 33: 655–660

    Article  PubMed  CAS  Google Scholar 

  12. Koch-Weser J, Klein SW, Foo-Canto U, Kastor JA, De Sanctis RW (1969) Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. N Engl J Med 281: 1253–1260

    Article  PubMed  CAS  Google Scholar 

  13. Lie KI, Wellens HJJ, van Capelle FJ, Durrer D (1974) Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med 291: 1324–1326

    Article  PubMed  CAS  Google Scholar 

  14. Lie KI, Liem KL, Louridtz WJ, Janse WJ, Willebrands AF, Durrer D (1978) Efficacy of lidocaine in preventing primary ventricular fibrillation within 1 hour after a 300 mg intramuscular injection. A double-blind, randomized study of 300 hospitalized patients with acute myocardial infarction. Am J Cardiol 42: 486–488

    Article  PubMed  CAS  Google Scholar 

  15. Nicholls DP, Haybyrne T, Barnes PC (1980) Intravenous and oral disopyramide after myocardial infarction. Lancet 2: 936–938

    Article  PubMed  CAS  Google Scholar 

  16. O’Brien KP, Taylor PM, Croxson RS (1973) Prophylactic lidocaine in hospital patients with acute myocardial infarction. Med J Aust 2 (Suppl): 36–37

    PubMed  Google Scholar 

  17. Peter T, Ross D, Duffield A, Luxton M, Harper R, Hunt D, Sloman G (1978) Effect of survival after myocardial infarction of long-term treatment with Phenytoin. Br Heart J 40: 1356–1360

    Article  PubMed  CAS  Google Scholar 

  18. Pitt S, Lipp H, Anderson ST (1971) Lignocaine given prophylactically to patients with acute myocardial infarction. Lancet 1: 612–616

    Article  PubMed  CAS  Google Scholar 

  19. Raynell PC (1961) Prophylactic procaine amide in myocardial infarction. Br Heart J 23: 421–424

    Article  Google Scholar 

  20. Ryden L, Amman K, Conradson TB, Hofvendahl S, Mortensen O, Smedgard P (1980) Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction. Am Heart J 100: 1006–1012

    Article  PubMed  CAS  Google Scholar 

  21. Valentine PA, Frew JL, Mashford ML, Sloman JG (1974) Lidocaine in the prevention of sudden death in the prehospital phase of acute infarction. A double-blind study. N Engl J Med 291: 1327–1331

    Google Scholar 

  22. Wilcox RG, Rowley JM, Hampton JR, Mitchell JRA, Roland JM, Banks DC (1980) Randomized placebo-controlled trial comparing Oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet 2: 764–769

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Kardiologie, 1. Medizinische Klinik, Christian-Albrechts-Universität Kiel, Schittenhelmstr. 12, 2300, Kiel, Germany

    Frau Dr. sc. med. K. Rathgen

Authors
  1. Frau Dr. sc. med. K. Rathgen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Klinik, Technischen Universität München Klinikum rechts der Isar, Ismaninger Straße 22, 8000, München 80, Germany

    Georg Schmidt

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Rathgen, K. (1991). Klinische Studien zur Verbesserung der Prognose von Postinfarktpatienten mittels antiarrhythmischer Therapie. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85414-9_2

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85415-6

  • Online ISBN: 978-3-642-85414-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation